Skip to main content
NCBI home page
AAPS PharmSci logoLink to AAPS PharmSci
. 2002 Nov 6;4(4):224–230. doi: 10.1208/ps040444

Chitosan and sodium alginate—Based bioadhesive vaginal tablets

Amal El-Kamel 1,✉, Magda Sokar 2, Viviane Naggar 2, Safaa Al Gamal 2
PMCID: PMC2751333  PMID: 12646014

Abstract

Metronidazole was formulated in mucoadhesive vaginal tablets by directly compressing the natural cationic polymer chitosan, loosely cross-linked with glutaraldehyde, together with sodium alginate with or ine cellulose (MCC). Sodium carboxymethylcellulose (CMC) was added to some of the formulations. The drug content in tablets was 20%. Drug dissolution rate studies from tablets were carried out in buffer pH 4.8 and distilled water. Swelling indices and adhesion forces were also measured for all formulations. The formula (FIII) containing 6% chitosan, 24% sodium alginate, 30% sodium CMC, and 20% MCC showed adequate release properties in both media and gave lower values of swelling index compared with the other examined formulations. FIII also proved to have good adhesion properties with minimum applied weights. Moreover, its release properties (% dissolution efficiency, DE) in buffer pH 4.8, as well as release mechanism (n values), were negligibly affected by aging. Thus, this formula may be considered a good candidate for vaginal mucoadhesive dosage forms.

Keywords: metronidazole, chitosan, sodium alginate, mucoadhesion, swelling, release study

References

  • 1.Miyazaki S, Nakayama A, Oda M, Takada M, Attwood D. Chitosan and sodium alginate based bioadhesive tablets for intraoral drug delivery. Biol Pharm Bull. 1994;17:745–747. doi: 10.1248/bpb.17.745. [DOI] [PubMed] [Google Scholar]
  • 2.Felt O, Buri P, Gurny R. Chitosan: a unique polysaccharide for drug delivery. Drug Dev Ind Pharm. 1998;24:979–993. doi: 10.3109/03639049809089942. [DOI] [PubMed] [Google Scholar]
  • 3.Peppas NA, Bury PA. Surface interfacial and molecular aspects of polymer bioadhesion on soft tissues. J Control Rel. 1985;2:257–275. doi: 10.1016/0168-3659(85)90050-1. [DOI] [Google Scholar]
  • 4.Robinson JR, Mlynek GM. Bioadhesive and phase-change polymers for ocular drug delivery. Adv Drug Del Rev. 1985;16:45–50. doi: 10.1016/0169-409X(95)00013-W. [DOI] [Google Scholar]
  • 5.Lehr CM, Bouwstra JA, Schacht EH, Junginger HE. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int J Pharm. 1992;78:43–48. doi: 10.1016/0378-5173(92)90353-4. [DOI] [Google Scholar]
  • 6.Sawayanagi Y, Nambu N, Nagai T. Use of chitosan for sustained release preparations of water soluble drugs. Chem Pharm Bull. 1982;30:4213–4215. doi: 10.1248/cpb.30.4213. [DOI] [PubMed] [Google Scholar]
  • 7.Nigalaye AG, Adusumilli P, Bolton S. Investigation of prolonged drug release from matrix formulations of chitosan. Drug Dev Ind Pharm. 1990;16:449–467. doi: 10.3109/03639049009114897. [DOI] [Google Scholar]
  • 8.Fukuda H, Kikuchi Y. Polyelectrolyte complexes of sodium carboxymethylcellulose with chitosan. Makromol Chem. 1979;180:1631–1633. doi: 10.1002/macp.1979.021800629. [DOI] [Google Scholar]
  • 9.Lin SY, Lin PC. Effect of acid type, acetic acid and sodium carboxymethylcellulose concentrations on the formation, micromeretic, dissolution and floating properties of theophylline chitosan microcapsules. Chem Pharm Bull. 1992;40:2491–2497. [Google Scholar]
  • 10.Meshali MM, Gabr KE. Effect of interpolymer complex formation of chitosan with pectin or acacia on the release behaviour of chlorpromazine HCL. Int J Pharm. 1993;89:177–181. doi: 10.1016/0378-5173(93)90241-7. [DOI] [Google Scholar]
  • 11.Lee JW, Park JH, Robinson JR. Bioadhesive-based dosage forms: the next generation. J Pharm Sci. 2000;89:850–866. doi: 10.1002/1520-6017(200007)89:7<850::AID-JPS2>3.0.CO;2-G. [DOI] [PubMed] [Google Scholar]
  • 12.Hou W, Miyazaki S, Takada M, Komai T. Sustained release of indomethacin from chitosan granules. Chem Pharm Bull. 1985;33:3986–3992. doi: 10.1248/cpb.33.3986. [DOI] [PubMed] [Google Scholar]
  • 13.Wang YM, Sato H, Adachi I, Horikoshi I. Optimization of the formulation design of chitosan microspheres containing cisplatin. J Pharm Sci. 1996;85:1204–1210. doi: 10.1021/js960092j. [DOI] [PubMed] [Google Scholar]
  • 14.Parodi B, Russo E, Caviglioli G, Cafaggi S, Bignardi G. Development and characterization of a buccoadhesive dosage form of oxycodone hydrochloride. Drug Dev Ind Pharm. 1996;22:445–450. doi: 10.3109/03639049609069353. [DOI] [Google Scholar]
  • 15.Chitnis VS, Malshe VS, Lalla JK. Bioadhesive polymers “synthesis, evaluation and application in controlled release tablets. Drug Dev Ind Pharm. 1991;17:879–892. doi: 10.3109/03639049109040824. [DOI] [Google Scholar]
  • 16.Khan KA. The concept of dissolution efficiency. J Pharm Pharmacol. 1975;27:48–49. doi: 10.1111/j.2042-7158.1975.tb09378.x. [DOI] [PubMed] [Google Scholar]
  • 17.Nogami H, Nagai T, Fukuoka E, Sonobe T. Disintegration of the aspirin tablets containing potato starch and microcrystalline cellulose in various concentrations. Chem Pharm Bull. 1969;17:1450–1455. doi: 10.1248/cpb.17.1450. [DOI] [PubMed] [Google Scholar]
  • 18.Miyazaki S, Yamaguchi H, Yokouchi C, Takada M, Hou WM. Sustained release of indomethacin from chitosan granules in beagle dogs. J Pharm Pharmacol. 1988;40:642–643. doi: 10.1111/j.2042-7158.1988.tb05325.x. [DOI] [PubMed] [Google Scholar]
  • 19.Devi KP, Rao KVR, Baveja S, Fathi M, Roth M. Zero-order release formulation of oxprenclol hydrochloride with swelling and erosion control. Pharm Res. 1989;6:313–317. doi: 10.1023/A:1015998424548. [DOI] [PubMed] [Google Scholar]
  • 20.Koh GL, Tucker LG. Characterization of sodium carboxymethylcellulose gelatin complex coacervation by viscosity, turbidity and coacervate wet weight and volume measurements. J Pharm Pharmacol. 1988;40:233–236. doi: 10.1111/j.2042-7158.1988.tb05234.x. [DOI] [PubMed] [Google Scholar]
  • 21.Ofner CM, Schnaare RL, Schwartz JB. Oral aqueous suspensions. In: Liebermann HA, Rieger MM, Banker GS, editors. Pharmaceutical Dosage Forms: Disperse Systems. 2nd ed. New York, NY: Marcel Dekker Inc; 1996. pp. 149–181. [Google Scholar]
  • 22.Dolz M, Roldan C, Herraez JV, Belda R, Sobrino P. Viscoelastic behaviour of MCC hydrogels. Pharm Acta Helv. 1991;66:281–285. [Google Scholar]
  • 23.Peppas NA. Analysis of Fickian and non Fickian drug release from polymers. Pharm Acta Helv. 1985;60:110–111. [PubMed] [Google Scholar]
  • 24.Chung HS, Park H, Kelly P, Robinson JR. Bioadhesive polymers as platforms for oral controlled drug delivery, II: synthesis and evaluation of some swelling water insoluble bioadhesive polymers. J Pharm Sci. 1985;74:399–405. doi: 10.1002/jps.2600740407. [DOI] [PubMed] [Google Scholar]
  • 25.Bottenberg P, Cleymaet R, Muynck C, et al. Development and testing of bioadhesive fluoride-containing slow-release tablets for oral use. J Pharm Pharmacol. 1991;43:457–464. doi: 10.1111/j.2042-7158.1991.tb03514.x. [DOI] [PubMed] [Google Scholar]
  • 26.Carcia-Gonzalez N, Kellaway IW, Blanco-Fuente H. Design and evaluation of buccoadhesive metoclopramide hydrogels composed of poly (-acrylic acid) cross-linked with sucrose. Int J Pharm. 1993;100:65–70. doi: 10.1016/0378-5173(93)90076-R. [DOI] [Google Scholar]
  • 27.Noble L, Gray AI, Sadiq L, Uchegbu IF. A noncovalently crosslinked chitosan based hydrogel. Int J Pharm. 1999;192:173–182. doi: 10.1016/S0378-5173(99)00306-3. [DOI] [PubMed] [Google Scholar]
  • 28.Mitchell K, Ford JL, Armstrong DJ, Elliott PNC, Hogan JE, Rostron C. The influence of drugs on the properties of gels and swelling characteristics of matrices containing methyl cellulose or hydroxypropylmethlyl cellulose. Int J Pharm. 1993;100:165–173. doi: 10.1016/0378-5173(93)90087-V. [DOI] [Google Scholar]
  • 29.Wan LSC, Heng PWS, Wong LF. Relationship between swelling and drug release in a hydrophilic matrix. Drug Dev Ind Pharm. 1993;19:1201–1210. doi: 10.3109/03639049309063012. [DOI] [Google Scholar]
  • 30.Tur KM, Ch ng HS. Evaluation of possible mechanism(s) of bioadhesion. Int J Pharm. 1998;160:61–74. doi: 10.1016/S0378-5173(97)00297-4. [DOI] [Google Scholar]
  • 31.Xu G, Sunada H. Influence of formulation change on drug release kinetics from hydroxypropylmethyl cellulose matrix tablets. Chem Pharm Bull. 1995;43:483–487. doi: 10.1248/cpb.43.483. [DOI] [PubMed] [Google Scholar]
  • 32.Mortazavi SA, Carpenter BG, Smart JD. A comparative study on the role played by mucus glycoproteins in the rheological behaviour of the mucoadhesive/mucosal interface. Int J Pharm. 1993;94:195–201. doi: 10.1016/0378-5173(93)90024-A. [DOI] [Google Scholar]

Articles from AAPS PharmSci are provided here courtesy of American Association of Pharmaceutical Scientists

RESOURCES